The medication was designed to reach its full potential over four weeks
Congress passed a bill in the 1990s prohibiting Medicare part-B from covering cosmetic treatments, which has prevented it from covering drugs prescribed solely for weight loss, though it does cover GLP-1s in some cases for heart disease, according to Joseph Levy, an assistant professor of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health
Additionally, both studies compared GLP-1RAs with SGLT-2 inhibitors, but the risk of intestinal obstruction associated with GLP-1RAs compared to other commonly used anti-diabetic medications, including insulin and metformin, remains unknown
Neither directly affects UTI risk, but both require monitoring that should include kidney function tests, which can incidentally identify early urinary tract issues
It is important to remember that not all compounding pharmacies are created equal